These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 2404138

  • 1. Synthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzees.
    Warren RQ, Wolf H, Shuler KR, Eichberg JW, Zajac RA, Boswell RN, Kanda P, Kennedy RC.
    J Virol; 1990 Feb; 64(2):486-92. PubMed ID: 2404138
    [Abstract] [Full Text] [Related]

  • 2. Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States.
    Warren RQ, Nkya WM, Shao JF, Anderson SA, Wolf H, Hendrix CW, Kanda P, Wabuke M, Boswell RN, Redfield RR.
    J Clin Microbiol; 1992 Jan; 30(1):126-31. PubMed ID: 1370844
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fine specificity of the humoral immune response to HIV-1 GP160 in HIV-1 infected individuals from Tanzania.
    Nkya WM, Warren RQ, Wolf H, Hendrix CW, Tesha J, Redfield RR, Melcher GP, Burke DS, Kanda P, Kennedy RC.
    J Med Virol; 1992 May; 37(1):61-6. PubMed ID: 1619399
    [Abstract] [Full Text] [Related]

  • 6. Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160.
    Benjouad A, Gluckman JC, Rochat H, Montagnier L, Bahraoui E.
    J Virol; 1992 Apr; 66(4):2473-83. PubMed ID: 1347797
    [Abstract] [Full Text] [Related]

  • 7. Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.
    Bolmstedt A, Sjölander S, Hansen JE, Akerblom L, Hemming A, Hu SL, Morein B, Olofsson S.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):213-20. PubMed ID: 8673525
    [Abstract] [Full Text] [Related]

  • 8. Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.
    Pincus SH, Messer KG, Schwartz DH, Lewis GK, Graham BS, Blattner WA, Fisher G.
    J Clin Invest; 1993 May; 91(5):1987-96. PubMed ID: 7683694
    [Abstract] [Full Text] [Related]

  • 9. Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection.
    Pincus SH, Messer KG, Hu SL.
    J Clin Invest; 1994 Jan; 93(1):140-6. PubMed ID: 8282780
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjects.
    Wong MT, Warren RQ, Anderson SA, Dolan MJ, Hendrix CW, Blatt SP, Melcher GP, Boswell RN, Kennedy RC.
    J Infect Dis; 1993 Dec; 168(6):1523-7. PubMed ID: 7504036
    [Abstract] [Full Text] [Related]

  • 12. Fine specificity of anti-V3 antibodies induced in chimpanzees by HIV candidate vaccines.
    Coëffier E, Girard M, Barré-Sinoussi F, Meignier B, Muchmore E, Fultz PN, LeClerc C.
    AIDS Res Hum Retroviruses; 1998 Aug 10; 14(12):1023-34. PubMed ID: 9718117
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins.
    Neurath AR, Jiang S, Strick N, Kolbe H, Kieny MP, Muchmore E, Girard M.
    AIDS Res Hum Retroviruses; 1991 Oct 10; 7(10):813-23. PubMed ID: 1720628
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans.
    Nehete PN, Schapiro SJ, Johnson PC, Murthy KK, Satterfield WC, Sastry KJ.
    Viral Immunol; 1998 Oct 10; 11(3):147-58. PubMed ID: 9918406
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunogenicity of synthetic peptides corresponding to various epitopes of the human immunodeficiency virus envelope protein.
    Zaghouani H, Hall B, Shah H, Bona C.
    Adv Exp Med Biol; 1991 Oct 10; 303():53-62. PubMed ID: 1725238
    [No Abstract] [Full Text] [Related]

  • 19. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura.
    Bettaieb A, Fromont P, Louache F, Oksenhendler E, Vainchenker W, Duédari N, Bierling P.
    Blood; 1992 Jul 01; 80(1):162-9. PubMed ID: 1611083
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.